Search results for "France"

showing 10 items of 2879 documents

Acceptability, attitudes and knowledge towards Transcranial Magnetic Stimulation (TMS) among psychiatrists in France

2020

Abstract Background Non-invasive brain stimulation techniques are becoming a part of psychiatrists’ therapeutic arsenal. Proof of TMS effectiveness and its indications are becoming clearer. While international recommendations exist, and many countries have already recognized the use of these techniques, the French situation is peculiar since no recommendation has been published by the High Authority of Health. Consequently, those techniques are not reimbursed by the healthcare service, few practitioners are trained, some are criticized for using it, and practices remain very heterogeneous. It is therefore important to investigate what slows down the development of these techniques. The obje…

AdultMaleHealth Knowledge Attitudes Practice[SDV]Life Sciences [q-bio]medicine.medical_treatmentApplied psychologyHigh authorityObservationSample (statistics)behavioral disciplines and activitiesHealth Services Accessibility03 medical and health sciences0302 clinical medicineArts and Humanities (miscellaneous)Variable domainSurveys and QuestionnairesmedicineHumansComputingMilieux_MISCELLANEOUSAgedPsychiatryDepressive DisorderMental DisordersTraining levelMiddle AgedTranscranial Magnetic StimulationProfessional culture030227 psychiatry[SDV] Life Sciences [q-bio]Transcranial magnetic stimulationPsychiatry and Mental healthSocioeconomic FactorsPsychoanalytic TheoryBrain stimulationFemaleFranceHealthcare servicePsychologyL'Encéphale
researchProduct

For me the taste of soy is not a barrier to its consumption. And how about you?

2012

International audience; This research investigates the cultural influence on beliefs about and attitudes towards soy foods (French from France vs. Vietnamese from Vietnam) and possible change of beliefs and attitudes and soy consumption habits with a change in cultural environment (French from France vs. French from Vietnam, Vietnamese from Vietnam vs. Vietnamese from France) of French and Vietnamese participants, two countries with very different soy food consumption. Expressed beliefs and attitudes of soy foods resulting from discussions in focus groups, conducted in both countries, were collected and used to derive a questionnaire. French participants differ mainly from Vietnamese partic…

AdultMaleHealth Knowledge Attitudes Practicemedia_common.quotation_subjectVietnamese[ SDV.AEN ] Life Sciences [q-bio]/Food and NutritionCultureHealth benefitsSocial EnvironmentYoung AdultCultural diversitySurveys and QuestionnairesFood choiceHumansSocioeconomicsskin and connective tissue diseasesGeneral Psychologymedia_commonConsumption (economics)Nutrition and DieteticsTaste (sociology)CommerceSoy FoodsFeeding BehaviorFocus GroupsMiddle AgedFocus grouplanguage.human_languageDietVietnamTastelanguageFemaleHabitFranceSoybeanssense organsPsychologySocial psychology[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition
researchProduct

Management and treatment of chronic hepatitis B virus infection in HIV positive and negative patients: The EPIB 2008 study

2010

To compare the management and the virological and serological efficacy of treatments for chronic hepatitis B (CHB) in HIV positive and negative patients.Two hundred and forty-six HIV positive and 205 HIV negative consecutive patients with past or present CHB, seen in October 2008 in participating departments, were included in a multicenter study. All the data were retrospectively collected from the first visit to October 2008 through a standardized questionnaire.Compared to HIV negative patients, HIV positive patients more often presented positive HBeAg (46.4% vs. 32.8%, p=0.01), HBV genotype A (54.8% vs. 17.1%, p0.0001), co-infection with HCV (12.4% vs. 5.9%, p=0.0002) or HDV (12.6% vs. 2.…

AdultMaleHepatitis B virusmedicine.medical_specialtyOrganophosphonatesHIV InfectionsAntiviral AgentsSerologyHepatitis B AntigensHepatitis B ChronicPharmacotherapyAcquired immunodeficiency syndrome (AIDS)Surveys and QuestionnairesInternal medicinemedicineHumansHepatitis B AntibodiesTenofovirSidaRetrospective StudiesHepatologybiologybusiness.industryAdeninevirus diseasesMiddle AgedHepatitis Bbiology.organism_classificationmedicine.diseaseHBeAgLentivirusImmunologyFemaleFranceViral diseasebusinessJournal of Hepatology
researchProduct

Incidence of cardiovascular events and risk markers in a prospective study of children diagnosed with Marfan syndrome

2018

Little is known about the incidence of cardiovascular events (CVEs) and their associated risk markers in children with Marfan syndrome (MFS).To assess the incidence of CVEs and determine risk markers in a cohort diagnosed with Marfan syndrome during childhood and followed for several years.From a French multicentre nationwide database, 462 patients with MFS diagnosed during childhood were included prospectively. Patients' files were screened for a period of 20 years (1993-2013). CVEs (e.g. death, aortic dissection, cardiac valve or aortic root surgery) were assessed during the prospective follow-up.Median (interquartile range) age at the end of follow-up was 17.2 (11.1-21.3) years. CVEs wer…

AdultMaleMarfan syndromePediatricsmedicine.medical_specialtyTime FactorsAdolescentDatabases Factual030204 cardiovascular system & hematologyRisk AssessmentMarfan SyndromeYoung Adult03 medical and health sciences0302 clinical medicineRisk FactorsInterquartile rangeCardiac valvemedicineHumansProspective Studies030212 general & internal medicineChildProspective cohort studyAortic dissectionbusiness.industryIncidenceIncidence (epidemiology)Age FactorsInfantGeneral MedicinePrognosismedicine.diseaseConfidence intervalCardiovascular DiseasesChild PreschoolCohortFemaleFranceCardiology and Cardiovascular MedicinebusinessArchives of Cardiovascular Diseases
researchProduct

Olfactory categorization: a developmental study.

2012

International audience; This study examined the ability of children to classify fruit and flower odors. We asked four groups of children (4-11 years of age) and a group of adults to identify, categorize, and evaluate the edibility, liking, and typicality of 12 fruit and flower odors. Results showed an increase in interindividual agreement with age for the taxonomic (fruit/flower) and function-based (edible/nonedible) categories but not for the hedonic component. So, it seems that this hedonic component is not the explicit basis for this increase in interindividual agreement when categorizing an odor as a fruit/flower odor or as being edible or nonedible. An age-related trend was also observ…

AdultMaleOlfactory perceptionOlfactory categorizationEstheticsLavenderConcept FormationHuman Development[ SDV.AEN ] Life Sciences [q-bio]/Food and NutritionExperimental and Cognitive PsychologyFlowers050105 experimental psychologyDevelopmental psychologyToxicologyDevelopmental and Educational PsychologyHumans0501 psychology and cognitive sciencesChildAgedAge differences05 social sciencesfood and beveragesRecognition PsychologyMiddle AgedClassificationOlfactory PerceptionCategorizationOdorChild PreschoolFruitLinear ModelsFemaleFrancePlants EdiblePsychology[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition050104 developmental & child psychology
researchProduct

Estimation de l’incidence des hémopathies malignes en France entre 1980 et 2012

2016

International audience; BACKGROUND:The classification of hematological malignancies (HMs) has changed in recent decades. For the first time, the French network of cancer registries (Francim) provides estimates for incidence and trends of HM in France between 1980 and 2012 for major HM subtypes.METHODS:Incidence was directly estimated by modeling the incidence rates measured in the cancer registry area. For each HM subtype, a "usable incidence period" was defined a priori, corresponding to the years for which all the registries collected them in a homogeneous way. For both sexes and each HM subtype, age-period-cohort models were used to estimate national incidence trends.RESULTS:Overall in F…

AdultMaleOncologyPediatricsmedicine.medical_specialtyRegistryAdolescentEpidemiologyChronic lymphocytic leukemiaFollicular lymphoma[SDV.CAN]Life Sciences [q-bio]/Cancer[ SDV.CAN ] Life Sciences [q-bio]/CancerHematological malignanciesYoung Adult03 medical and health sciences0302 clinical medicineNeoplasmsInternal medicinemedicineHumansRegistriesAgedAged 80 and overbusiness.industryMyelodysplastic syndromesIncidence (epidemiology)IncidencePublic Health Environmental and Occupational HealthCancer[ SDV.SPEE ] Life Sciences [q-bio]/Santé publique et épidémiologieHémopathies malignesMiddle AgedPlasma cell neoplasmmedicine.disease3. Good healthLymphomaCancer registryTendancesHematologic Neoplasms030220 oncology & carcinogenesisFemale[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieFranceTrendsbusinessRegistre de population030215 immunology
researchProduct

INFLUENCE OF ISLET TRANSPORTATION ON PANCREATIC ISLET ALLOTRANSPLANTATION IN TYPE 1 DIABETIC PATIENTS WITHIN THE SWISS-FRENCH GRAGIL NETWORK

2004

The influence of islet transportation on pancreatic islet allotransplantation in type 1 diabetic patients was evaluated within the GRAGIL network.From December 2001 to April 2003, 16 human pancreatic islet transplants were performed in 9 type 1 diabetic patients with an established kidney graft (functioning for at least 6 months) in four centers of the GRAGIL network. Islet isolation was performed in a core laboratory in Geneva, and the islet preparations were shipped by ambulance to each center for transplantation. One month after transplantation, the efficiency of the graft was assessed according to islet transportation time (ITT): ITT less than 2 hours (group 1, n=5), and ITT greater tha…

AdultMaleOncologyendocrine systemmedicine.medical_specialtyTime FactorsTissue and Organ Procurementendocrine system diseasesTissue and Organ Procurement/methodsmedicine.medical_treatmentIslets of Langerhans TransplantationTransportationHemoglobin A Glycosylated/metabolismInternal medicineImmunopathologymedicineHumansGlycated HemoglobinAutoimmune diseaseTransplantationType 1 diabetesgeographygeography.geographical_feature_categoryddc:617C-Peptidebusiness.industryGraft SurvivalIslets of Langerhans Transplantation/methods/physiologyCreatinine/bloodMiddle Agedmedicine.diseaseIsletTransplantationDiabetes Mellitus Type 1EndocrinologyDiabetes Mellitus Type 1/surgeryCreatinineC-Peptide/bloodFemaleFrancebusinessSwitzerlandAllotransplantationTransplantation
researchProduct

Patterns of adjuvant chemotherapy for stage II and III colon cancer in France and Italy

2013

European guidelines recommend adjuvant chemotherapy for stage III colon cancer but not for stage II.To determine the extent to which adjuvant chemotherapy was used in Italy and France.A common retrospective database of 2186 colon cancers diagnosed between 2003 and 2005 was analysed according to age, stage and presenting features.38.9% of patients with stage II and 64.6% with stage III received chemotherapy in Italy, 21.7% and 65.1% in France. For stage II, the association between country and chemotherapy was only significant in patients diagnosed out of emergency (ORItaly/France: 3.05 [2.12-4.37], p0.001) whereas patients diagnosed in emergency were as likely to receive chemotherapy in both…

AdultMaleOncologymedicine.medical_specialtyAdolescentAdjuvant chemotherapyColorectal cancermedicine.medical_treatmentStage iiLower riskDisease-Free SurvivalInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansIn patientStage (cooking)ChildAgedNeoplasm StagingRetrospective StudiesAged 80 and overChemotherapyHepatologybusiness.industryInfant NewbornGastroenterologyInfantMiddle Agedmedicine.diseaseCancer registryItalyChemotherapy AdjuvantChild PreschoolColonic NeoplasmsPractice Guidelines as TopicFemaleFranceGuideline AdherencebusinessDigestive and Liver Disease
researchProduct

Conditional net survival: Relevant prognostic information for colorectal cancer survivors. A French population-based study

2015

Abstract Background Traditionally, survival estimates have been reported as survival from the time of diagnosis. A patient's probability of survival changes according to time elapsed since the diagnosis and this is known as conditional survival. The aim was to estimate 5-year net conditional survival in patients with colorectal cancer in a well-defined French population at yearly intervals up to 5 years. Methods Our study included 18,300 colorectal cancers diagnosed between 1976 and 2008 and registered in the population-based digestive cancer registry of Burgundy (France). We calculated conditional 5-year net survival, using the Pohar Perme estimator, for every additional year survived afte…

AdultMaleOncologymedicine.medical_specialtyColorectal cancerPopulationStage iiConditional survivalInternal medicineStatisticsmedicineHumansIn patientRegistrieseducationNet SurvivalAgedNeoplasm StagingAged 80 and overeducation.field_of_studyHepatologybusiness.industryGastroenterologyCancerMiddle AgedPrognosismedicine.diseaseSurvival AnalysisPopulation based studyFemaleFranceColorectal NeoplasmsbusinessDigestive and Liver Disease
researchProduct

Avelumab versus standard second line treatment chemotherapy in metastatic colorectal cancer patients with microsatellite instability: The SAMCO-PRODI…

2021

Abstract Immune checkpoint inhibitors have failed in treating metastatic colorectal cancer (mCRC) patients except those with dMMR/MSI tumors. However, until very recently we had only non-comparative promising data in this population with anti-programmed cell death 1/ programmed cell death ligand 1 (PD1/PD-L1) antibodies alone or combined with anti- cytotoxic T-lymphocyte-associated protein 4 (CTLA4) antibodies. This comparative phase II trial (NCT 03186326), conducted in more than 100 centers in France, will include dMMR/MSI mCRC patients with progression after a first-line treatment with chemotherapy ± targeted therapies, to evaluate efficacy and safety of the anti-PDL1 Avelumab versus a s…

AdultMaleOncologymedicine.medical_specialtyColorectal cancermedicine.medical_treatmentPopulationECOG Performance StatusAntibodies Monoclonal HumanizedAvelumab03 medical and health sciencesAntineoplastic Agents ImmunologicalClinical Trials Phase II as Topic0302 clinical medicineInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansMulticenter Studies as TopiceducationRandomized Controlled Trials as TopicChemotherapyeducation.field_of_studyHepatologybusiness.industryGastroenterologyMicrosatellite instabilityImmunotherapymedicine.diseaseProgression-Free SurvivalRegimen030220 oncology & carcinogenesisFemaleMicrosatellite Instability030211 gastroenterology & hepatologyFranceColorectal Neoplasmsbusinessmedicine.drugDigestive and Liver Disease
researchProduct